Carbohydrate Metabolism Practice Questions

Q: In what form does the product of glycolysis enter the TCA cycle?

Acetyl-CoA. **Explanation:** The end product of aerobic glycolysis is **Pyruvate**. However, the TCA cycle (Krebs cycle) occurs in the mitochondrial matrix and cannot directly utilize pyruvate. **1. Why Acetyl-CoA is correct:** Before entering the TCA cycle, pyruvate must undergo **oxidative decarboxylation** to form **Acetyl-CoA**. This reaction is catalyzed by the **Pyruvate Dehydrogenase (PDH) Complex**, a multi-enzyme cluster located in the inner mitochondrial membrane. Acetyl-CoA then condenses with Oxaloacetate (OAA) to form Citrate, marking the official start of the TCA cycle. Therefore, Acetyl-CoA is the "connecting link" or the actual substrate that enters the cycle. **2. Why other options are incorrect:** * **Pyruvate:** While it is the product of glycolysis, it is a 3-carbon molecule that must be converted to the 2-carbon Acetyl-CoA before it can participate in the TCA cycle. * **NADH:** This is a coenzyme produced during glycolysis and the TCA cycle. It enters the Electron Transport Chain (ETC) to generate ATP but does not "enter" the TCA cycle as a substrate. * **Glucose:** This is the starting substrate for glycolysis, not the product. **3. High-Yield Clinical Pearls for NEET-PG:** * **PDH Complex Requirements:** It requires five cofactors: **T**hiamine (B1), **R**iboflavin (B2), **N**iacin (B3), **P**antothenic acid (B5), and **L**ipoic acid (**T**ender **R**eeds **N**ever **P**lay **L**oose). * **Arsenic Poisoning:** Arsenite inhibits the PDH complex by binding to lipoic acid, leading to lactic acidosis and neurological symptoms. * **Regulation:** PDH is inhibited by its products (Acetyl-CoA and NADH) and activated by ADP and $Ca^{2+}$.

Q: Phosphofructokinase is the key enzyme of which metabolic pathway?

Glycolysis. **Explanation:** **Phosphofructokinase-1 (PFK-1)** is the most important regulatory and rate-limiting enzyme of **Glycolysis** (the Embden-Meyerhof pathway). It catalyzes the irreversible conversion of Fructose-6-phosphate to Fructose-1,6-bisphosphate using one molecule of ATP. This step is known as the "committed step" because once phosphorylated by PFK-1, the glucose metabolite is destined to complete the glycolytic pathway. **Analysis of Incorrect Options:** * **Glycogenolysis:** The rate-limiting enzyme is **Glycogen Phosphorylase**, which breaks down glycogen into glucose-1-phosphate. * **Glycogenesis:** The rate-limiting enzyme is **Glycogen Synthase**, responsible for forming $\alpha$-1,4-glycosidic bonds to synthesize glycogen. * **TCA Cycle:** The key regulatory enzyme is **Isocitrate Dehydrogenase**, which catalyzes the oxidative decarboxylation of isocitrate to $\alpha$-ketoglutarate. **High-Yield Clinical Pearls for NEET-PG:** * **Allosteric Regulation:** PFK-1 is allosterically **inhibited by ATP and Citrate** (signaling high energy status) and **activated by AMP and Fructose-2,6-bisphosphate**. * **Potent Activator:** Fructose-2,6-bisphosphate is the most potent physiological activator of PFK-1, produced by the bifunctional enzyme PFK-2. * **Clinical Correlation:** Deficiency of the M-isoform of PFK-1 in muscles leads to **Tarui Disease (Glycogen Storage Disease Type VII)**, characterized by exercise intolerance and muscle cramping. * **Insulin vs. Glucagon:** Insulin increases PFK-1 activity (promoting glycolysis), while glucagon decreases it.

Q: Which test is used to differentiate monosaccharides from disaccharides?

Barfoed's test. **Explanation:** The correct answer is **Barfoed’s test**. This test is specifically designed to distinguish between reducing monosaccharides and reducing disaccharides based on the speed of the reaction. **1. Why Barfoed’s test is correct:** Barfoed’s reagent consists of cupric acetate in dilute acetic acid (an acidic medium). Both monosaccharides and disaccharides can reduce cupric ions to cuprous oxide, forming a red precipitate. However, because the medium is acidic, monosaccharides (being stronger reducing agents) react much faster, typically within **2–3 minutes** of boiling. Reducing disaccharides (like lactose or maltose) require prolonged boiling (7–10 minutes) to show a reaction. **2. Analysis of Incorrect Options:** * **Benedict’s test:** Used to detect **reducing sugars** in general (e.g., glucose, fructose, lactose). It cannot differentiate between a monosaccharide and a disaccharide. * **Seliwanoff’s test:** Used to differentiate **keto-hexoses** (like fructose) from aldo-hexoses. It produces a cherry-red complex with ketoses. * **Rapid Furfural test:** Used to distinguish between **fructose (a keto-hexose)** and sucrose. It is a faster version of the Molisch test specifically for ketoses. **High-Yield Clinical Pearls for NEET-PG:** * **Barfoed’s Reagent:** Cupric acetate + Glacial acetic acid. * **Key distinction:** Monosaccharides = Scanty red precipitate in 7 mins. * **Osazone Test:** Another high-yield test where glucose and fructose form needle-shaped crystals, while lactose forms "powder-puff" or "hedgehog" shaped crystals. * **Bial’s Test:** Used specifically to detect **Pentoses** (e.g., ribose).

Q: All steps of N-glycosylation occur in the ER except?

Final trimming of the oligosaccharide. **Explanation:** N-glycosylation is a complex process where a pre-formed oligosaccharide is attached to the nitrogen atom of an **Asparagine (Asn)** residue. This process is spatially divided between the **Endoplasmic Reticulum (ER)** and the **Golgi apparatus**. **Why "Final trimming" is the correct answer:** The initial assembly of the core oligosaccharide and the initial trimming (removal of glucose and some mannose residues) occur in the **ER**. However, the **final trimming** and subsequent complex modifications (addition of galactose, sialic acid, or fucose) occur exclusively in the **Golgi apparatus**. Therefore, final trimming is not an ER-resident step. **Analysis of Incorrect Options:** * **A. Dolichol synthesis:** Dolichol phosphate is the essential lipid carrier located in the **ER membrane** upon which the oligosaccharide chain is built. * **B. Glycosyl transferase activity:** These enzymes are responsible for the sequential addition of sugars (N-acetylglucosamine and mannose) to the dolichol carrier within the **ER**. * **C. Protein-oligosaccharide transferase:** Also known as Oligosaccharyltransferase (OST), this enzyme complex resides in the **ER lumen** and catalyzes the transfer of the 14-sugar precursor from dolichol to the nascent protein. **High-Yield Clinical Pearls for NEET-PG:** * **Site of N-glycosylation:** Starts in ER, finishes in Golgi. (Contrast: **O-glycosylation** occurs exclusively in the Golgi). * **Sequence Motif:** N-glycosylation occurs at the **Asn-X-Ser/Thr** motif (where X is any amino acid except proline). * **Tunicamycin:** An antibiotic that inhibits the first step of N-glycosylation (blocks the formation of Dolichol-P-P-GlcNAC). * **I-Cell Disease:** Caused by a deficiency in phosphotransferase in the Golgi, leading to failure of mannose-6-phosphate tagging, causing lysosomal enzymes to be secreted extracellularly rather than reaching lysosomes.

Q: Which of the following reactions produces CO2?

HMP shunt pathway. **Explanation:** The correct answer is **B. HMP shunt pathway**. **1. Why HMP Shunt is correct:** The Hexose Monophosphate (HMP) Shunt, also known as the Pentose Phosphate Pathway (PPP), consists of an oxidative and a non-oxidative phase. In the **oxidative phase**, the enzyme **6-phosphogluconate dehydrogenase** catalyzes the conversion of 6-phosphogluconate to Ribulose-5-phosphate. This reaction involves **oxidative decarboxylation**, where a carbon atom is released as **CO₂** while simultaneously generating NADPH. This is the primary source of CO₂ in this pathway. **2. Why other options are incorrect:** * **A. Amino acid synthesis:** While some specific amino acid degradative pathways (like the Glucose-Alanine cycle or Urea cycle) involve CO₂ fixation or release, general synthesis pathways are typically anabolic and do not characteristically produce CO₂ as a primary byproduct in the same way respiratory pathways do. * **C. Glycolysis:** This is a high-yield distinction. Glycolysis is the anaerobic breakdown of glucose to pyruvate (in the cytoplasm). It involves 10 enzymatic steps, **none of which release CO₂**. CO₂ is only released once pyruvate enters the mitochondria and undergoes the Link Reaction (Pyruvate Dehydrogenase complex) or the TCA cycle. **Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of HMP Shunt:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **Key Products:** NADPH (for fatty acid synthesis and keeping glutathione reduced) and Ribose-5-phosphate (for nucleotide synthesis). * **Site:** Occurs entirely in the **cytosol**. It is highly active in tissues requiring NADPH, such as the adrenal cortex, liver, and RBCs. * **G6PD Deficiency:** Leads to hemolytic anemia due to the inability to neutralize free radicals in RBCs (low NADPH).

Q: Which of the following is NOT a product of the uronic acid pathway in humans?

Vitamin C. The **Uronic Acid Pathway** is an alternative pathway for glucose oxidation that occurs primarily in the liver. It does not generate ATP but is essential for the synthesis of specialized sugars and detoxification. ### Why Vitamin C is the Correct Answer In most mammals, the uronic acid pathway leads to the synthesis of **Ascorbic acid (Vitamin C)**. However, **humans, primates, and guinea pigs cannot synthesize Vitamin C**. This is due to the evolutionary absence of the enzyme **L-gulonolactone oxidase**. Therefore, Vitamin C is an essential dietary requirement for humans and is not a product of this pathway. ### Explanation of Incorrect Options * **Glucuronic Acid:** This is the primary product of the pathway. It is crucial for the **conjugation** of bilirubin, steroid hormones, and drugs (making them water-soluble for excretion). It is also a precursor for Glycosaminoglycans (GAGs). * **Pentoses:** The pathway produces **L-xylulose**, which is subsequently converted to D-xylulose 5-phosphate. This allows the uronic acid pathway to interface with the Pentose Phosphate Pathway (HMP Shunt). * **NADH:** While the pathway primarily involves **NADPH** and **NAD+**, the oxidation of L-gulonate to xylulose involves the reduction of NAD+ to **NADH**. (Note: Some texts focus on NADPH, but NADH is indeed a byproduct of the L-gulonate dehydrogenase step). ### High-Yield Clinical Pearls for NEET-PG * **Essential Pentosuria:** A rare autosomal recessive condition caused by a deficiency of **L-xylulose reductase**. Patients excrete large amounts of L-xylulose in the urine. It is a benign condition but can give a false-positive result for reducing sugars (Benedict’s test). * **Drug Interaction:** Drugs like **Phenobarbital** and **Aminopyrine** can induce the enzymes of the uronic acid pathway, increasing the rate of glucuronate formation. * **Key Enzyme:** Remember **L-gulonolactone oxidase** as the "missing enzyme" in humans.

Q: Which enzyme of glycolysis is also used in gluconeogenesis?

Phosphohexose isomerase. **Explanation:** The core concept in understanding the relationship between glycolysis and gluconeogenesis is identifying **reversible** versus **irreversible** steps. While glycolysis and gluconeogenesis share many enzymes, they differ at three critical regulatory checkpoints. **Why Phosphohexose Isomerase is Correct:** Phosphohexose isomerase (also known as Phosphoglucose isomerase) catalyzes the reversible conversion of **Glucose-6-Phosphate to Fructose-6-Phosphate**. Because the Gibbs free energy change ($\Delta G$) for this reaction is near zero, the enzyme functions in both directions depending on substrate concentration. Therefore, it is used in both glycolysis (breakdown) and gluconeogenesis (synthesis). **Why the Other Options are Incorrect:** Options A, B, and C represent the **three irreversible "bottleneck" steps** of glycolysis. These steps have a large negative $\Delta G$ and must be bypassed in gluconeogenesis by specific, different enzymes: * **Glucokinase/Hexokinase (Step 1):** Bypassed by *Glucose-6-phosphatase* in gluconeogenesis. * **Phosphofructokinase-1 (Step 3):** The rate-limiting step of glycolysis; bypassed by *Fructose-1,6-bisphosphatase*. * **Pyruvate Kinase (Step 10):** Bypassed by a two-step process involving *Pyruvate carboxylase* and *PEP carboxykinase (PEPCK)*. **High-Yield NEET-PG Pearls:** * **Reversible Enzymes:** All enzymes of glycolysis are shared with gluconeogenesis **EXCEPT** Hexokinase, PFK-1, and Pyruvate Kinase. * **Location:** Gluconeogenesis occurs primarily in the liver and kidney. * **Mnemonic for Irreversible Steps:** "**H**ighly **P**roud **P**yruvate" (Hexokinase, PFK-1, Pyruvate Kinase). * **Clinical Link:** Deficiencies in gluconeogenic enzymes (like Glucose-6-phosphatase) lead to **Von Gierke Disease**, characterized by severe fasting hypoglycemia.

Q: Which of the following is most effective for gluconeogenesis?

Acetyl CoA activates pyruvate carboxylase. **Explanation:** Gluconeogenesis is the metabolic pathway that results in the generation of glucose from non-carbohydrate precursors. The regulation of this pathway is crucial for maintaining blood glucose levels during fasting. **Why Option B is Correct:** The conversion of pyruvate to oxaloacetate by **pyruvate carboxylase** is the first committed step of gluconeogenesis. This enzyme is an obligate allosteric enzyme that requires **Acetyl CoA** for its activation. When Acetyl CoA levels rise (typically from fatty acid oxidation during fasting), it signals that the TCA cycle is saturated and diverts pyruvate toward gluconeogenesis instead of oxidative decarboxylation. **Analysis of Incorrect Options:** * **Option A:** While it is true that Fructose 2,6-bisphosphate inhibits Fructose 1,6-bisphosphatase, this action **inhibits** gluconeogenesis. The question asks for what is effective *for* (promotes) the process. * **Option C:** This is the opposite of the physiological reality; Acetyl CoA is a potent activator, not an inhibitor, of pyruvate carboxylase. * **Option D:** Citrate does activate Acetyl CoA Carboxylase, but this is the rate-limiting step for **Fatty Acid Synthesis (Lipogenesis)**, not gluconeogenesis. **High-Yield Clinical Pearls for NEET-PG:** * **Biotin (Vitamin B7):** Pyruvate carboxylase requires Biotin as a cofactor. Deficiency (often due to raw egg white consumption/avidin) impairs gluconeogenesis. * **Reciprocal Regulation:** Acetyl CoA simultaneously inhibits the Pyruvate Dehydrogenase (PDH) complex while activating Pyruvate Carboxylase, ensuring pyruvate is not wasted in the TCA cycle when glucose is needed. * **Location:** Pyruvate carboxylase is a **mitochondrial** enzyme, whereas the subsequent steps of gluconeogenesis occur in the cytosol.

Question 1

In what form does the product of glycolysis enter the TCA cycle?

Accepted Answer

Acetyl-CoA

Answer

Pyruvate

Answer

NADH

Answer

Glucose

Question 2

Phosphofructokinase is the key enzyme of which metabolic pathway?

Accepted Answer

Glycolysis

Answer

Glycogenolysis

Answer

Glycogenesis

Answer

TCA cycle

Question 3

Which test is used to differentiate monosaccharides from disaccharides?

Accepted Answer

Barfoed's test

Answer

Benedict's test

Answer

Seliwanoff's test

Answer

Rapid furfural test

Question 4

Glyconeogenic capability of a cell is determined by the presence of which enzyme?

Accepted Answer

Fructose 1,6-bisphosphatase

Answer

Pyruvate dehydrogenase

Answer

Glucose 6 phosphatase

Answer

Pyruvate carboxylase

Question 5

All steps of N-glycosylation occur in the ER except?

Accepted Answer

Final trimming of the oligosaccharide

Answer

Dolichol synthesis

Answer

Glycosyl transferase activity

Answer

Protein-oligosaccharide transferase activity

Question 6

Caffeine, a methyl xanthine, has been added to a variety of cell types. Which one of the following would be expected in various cell types treated with caffeine and epinephrine?

Accepted Answer

Decreased activity of liver glycogen synthase

Answer

Decreased activity of liver PKA

Answer

Decreased activity of muscle PKA

Answer

Increased activity of liver pyruvate kinase

Question 7

Which of the following reactions produces CO2?

Accepted Answer

HMP shunt pathway

Answer

Amino acid synthesis

Answer

Glycolysis

Answer

None of the above

Question 8

Which of the following is NOT a product of the uronic acid pathway in humans?

Accepted Answer

Vitamin C

Answer

Pentoses

Answer

NADH

Answer

Glucuronic acid

Question 9

Which enzyme of glycolysis is also used in gluconeogenesis?

Accepted Answer

Phosphohexose isomerase

Answer

Glucokinase

Answer

Phosphofructokinase

Answer

Pyruvate kinase

Question 10

Which of the following is most effective for gluconeogenesis?

Accepted Answer

Acetyl CoA activates pyruvate carboxylase

Answer

Fructose 2,6 bisphosphate inhibits fructose 1,6 bisphosphatase

Answer

Acetyl CoA inhibits pyruvate carboxylase

Answer

Citrate activates acetyl CoA carboxylase

Carbohydrate Metabolism — MCQs

Carbohydrate Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?